Rosada, Rogério Silva; Moreira, Ana Paula; Frantz, Fabiani Gai 
; Puri, Raj K; Rahman, Aquilur; Standiford, Theodore J.; Bladés, Carlos Rodrigo Zárate; Silva, Célio Lopes ; Hogaboam, Cory M
Fonte: PLOS ONE. Unidade: FMRP
Assuntos: PSEUDOMONAS, FIBROSE PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSADA, Rogério Silva et al. Therapeutic efficacy of cintredekin besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to pseudomonas aeruginosa exotoxin A. PLOS ONE, v. 5, n. 1, p. e8721-1-e8721-7, 2010Tradução . . Acesso em: 30 set. 2024.APA
Rosada, R. S., Moreira, A. P., Frantz, F. G., Puri, R. K., Rahman, A., Standiford, T. J., et al. (2010). Therapeutic efficacy of cintredekin besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to pseudomonas aeruginosa exotoxin A. PLOS ONE, 5( 1), e8721-1-e8721-7.NLM
Rosada RS, Moreira AP, Frantz FG, Puri RK, Rahman A, Standiford TJ, Bladés CRZ, Silva CL, Hogaboam CM. Therapeutic efficacy of cintredekin besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to pseudomonas aeruginosa exotoxin A. PLOS ONE. 2010 ; 5( 1): e8721-1-e8721-7.[citado 2024 set. 30 ]Vancouver
Rosada RS, Moreira AP, Frantz FG, Puri RK, Rahman A, Standiford TJ, Bladés CRZ, Silva CL, Hogaboam CM. Therapeutic efficacy of cintredekin besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to pseudomonas aeruginosa exotoxin A. PLOS ONE. 2010 ; 5( 1): e8721-1-e8721-7.[citado 2024 set. 30 ]
